Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Amortization of Deferred Charges (2019 - 2025)

Historic Amortization of Deferred Charges for AdaptHealth (AHCO) over the last 7 years, with Q3 2025 value amounting to $1.3 million.

  • AdaptHealth's Amortization of Deferred Charges fell 1225.3% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 603.06%. This contributed to the annual value of $5.7 million for FY2024, which is 890.33% up from last year.
  • Per AdaptHealth's latest filing, its Amortization of Deferred Charges stood at $1.3 million for Q3 2025, which was down 1225.3% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, AdaptHealth's Amortization of Deferred Charges ranged from a high of $1.8 million in Q2 2025 and a low of $894000.0 during Q1 2021
  • Its 5-year average for Amortization of Deferred Charges is $1.4 million, with a median of $1.3 million in 2022.
  • Per our database at Business Quant, AdaptHealth's Amortization of Deferred Charges surged by 33423.65% in 2021 and then tumbled by 2575.16% in 2022.
  • AdaptHealth's Amortization of Deferred Charges (Quarter) stood at $1.3 million in 2021, then decreased by 1.73% to $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then rose by 11.09% to $1.5 million in 2024, then dropped by 8.33% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.8 million for Q2 2025, and $1.3 million during Q1 2025.